ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1327

Immune Cell Subsets and Risk of Incident Hip Fracture in Older Adults: The Cardiovascular Health Study

Rachel Elam1, Petra Buzkova2, Joseph Delaney3, Howard Fink4, Joshua Barzilay5, Laura Carbone1, Rick Saha1, John Robbins6, Kenneth Mukamal7, Rodrigo Valderrabano8, Bruce Psaty2, Russell Tracy9, Nels Olson9, Sally Huber10, Margaret Doyle9, Alan Landay11 and Jane Cauley12, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3University of Manitoba, Winnipeg, MB, Canada, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA, 6UC Davis, Davis, CA, 7Beth Israel Deaconess Medical Center, Boston, MA, 8Brigham and Women's Hospital, Boston, MA, 9University of Vermont, Burlington, VT, 10University of Vermont, Burlingon, VT, 11Rush University Medical Center, Chicago, IL, 12University of Pittsburgh, PIttsburgh, PA

Meeting: ACR Convergence 2022

Keywords: Aging, Fracture, immunology, innate immunity, osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Cell-mediated immunity may play a role in osteoporosis development. Fracture is the major consequence of osteoporosis. Thus, cell-mediated immunity may impact fracture risk. We evaluated whether innate and adaptive immune cell subsets in peripheral blood are risk factors for hip fracture.

Methods: The Cardiovascular Health Study (CHS) is a large U.S. cohort of community-dwelling, older (age ≥ 65 years) men and women. We included all CHS participants with at least one innate or adaptive immune cell phenotype measured by flow cytometry from cryopreserved cells collected in 1998-1999. Incident hip fractures were identified by participant report every six months following exposure measurement and confirmed by hospital medical record review. Participants were followed until first hip fracture event, death, loss to follow-up, or June 30, 2015, whichever occurred first. Cox hazard models with adjustment for fracture risk factors were used to evaluate associations of immune cell phenotypes with incident hip fracture in sex-stratified and combined analyses. T-helper 17 (Th17), γδ T, natural killer (NK) and differentiated/senescent CD4+CD28- T cell subsets were specified as subsets of interest for the primary analyses. In secondary analyses, 21 additional cell phenotypes were investigated (Table 1). A significance level of α=0.05 was used in primary and secondary analyses, with correction for multiple testing using the false discovery rate approach for the 21 immune subsets in the secondary analyses.

Results: A total of 259 incident hip fractures (n=197 in women; n=62 in men) occurred among 1928 persons over a median 9.7 years of follow-up. Baseline characteristics of the study population are described (Table 2). There were no statistically significant associations of the Th17, γδ T, NK or differentiated/senescent CD4+CD28- T cell subsets or other immune cell phenotypes with incident hip fracture in analyses combining men and women after multivariate adjustment. In women, a higher proportion of Th17 cells was associated with higher hip fracture risk (hazard ratio (HR) [95% confidence interval (CI)] of 1.18 [1.01, 1.39] per 1 standard deviation higher value) and a higher proportion of NK cells was associated with lower hip fracture risk (HR [95% CI] of 0.77 [0.60, 0.99]). In men, a higher proportion of γδ T cells was associated with lower hip fracture risk (HR [95% CI] of 0.60 [0.37, 0.98]) (Table 3). There was a significant difference between hazard ratios of incident hip fracture for men and women for NK (p=0.02) and γδ T (p=0.01) cell subsets in formal interaction testing.

Conclusion: Our study revealed important associations of immune cell phenotypes in peripheral blood and incident hip fracture that may differ by sex. Further mechanistic studies should explore whether these potential sex differences in these associations are mediated through osteoporosis development, bone quality and strength, bone turnover, sex steroid hormones or other pathways.

Supporting image 1

Immune Cell Phenotypes and their Cell-surface Markers

Supporting image 2

Baseline Characteristics of Study Population

Supporting image 3

Associations between Immune Cell Phenotypes and Incident Hip Fracture in the Primary Analyses, show as Hazard Ratios of Incident Hip Fracture per 1 Standard Deviation Higher Value from Final Multivariate Adjusted Models, Combined and Stratified by Sex


Disclosures: R. Elam, None; P. Buzkova, None; J. Delaney, None; H. Fink, None; J. Barzilay, None; L. Carbone, None; R. Saha, None; J. Robbins, None; K. Mukamal, None; R. Valderrabano, None; B. Psaty, None; R. Tracy, None; N. Olson, None; S. Huber, None; M. Doyle, None; A. Landay, None; J. Cauley, None.

To cite this abstract in AMA style:

Elam R, Buzkova P, Delaney J, Fink H, Barzilay J, Carbone L, Saha R, Robbins J, Mukamal K, Valderrabano R, Psaty B, Tracy R, Olson N, Huber S, Doyle M, Landay A, Cauley J. Immune Cell Subsets and Risk of Incident Hip Fracture in Older Adults: The Cardiovascular Health Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/immune-cell-subsets-and-risk-of-incident-hip-fracture-in-older-adults-the-cardiovascular-health-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-cell-subsets-and-risk-of-incident-hip-fracture-in-older-adults-the-cardiovascular-health-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology